switching from ozempic to retatrutide Is the next breakthrough in weight loss—or just another GLP-1 medication? In this video, we compare Retatrutide and Ozempic, breaking down how they work, what makes them different, and why many Retatrutide, a triple agonist, delivered
Description
Food noise has been around forever
Ro first integrated directly with Novo Nordisk in April 2025 and has been a key part of the manufacturer's direct-to-patient expansion to date.
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor
GLP-1 (glucagon-like peptide-1) is a natural hormone that helps regulate blood sugar, appetite, and fullness signals, so GLP-1 support products are generally aimed at supporting appetite control, digestion, and weight management habits
These medications, which include Novo Nordisks semaglutide, sold as Ozempic and Wegovy, and Eli Lillys tirzepatide, sold as Zepbound and Mounjaro, []
PlexusDx explains the interaction risks and how to manage both medications safely during your weight loss journey
